RESUMEN
BACKGROUND: Septic platelet transfusion reactions (SPTRs) are the most common, serious risk of transfusion. Because SPTRs result from donor skin flora or asymptomatic bacteremia, the use of single-donor platelets (SDPs) has been proposed to reduce the risk of SPTRs from the risks with pools of platelet concentrates (PCs). STUDY DESIGN AND METHODS: Beginning in 1986, all febrile transfusion reactions were evaluated by culture of the platelet bag. Confirmed SPTRs were identified by isolation of the same bacteria from the bag and the patient's blood or by positive Gram's stain of the bag that confirmed a positive platelet culture. In 1987, a program to minimize PC use in favor of SDP use was initiated as a means of reducing SPTRs. RESULTS: In 12 years, the use of SDPs increased from 51.7 percent to 99.4 percent of all platelet transfusions at one institution. SPTRs fell from three events in 1 year to the current rate of one event per year. The incidence of SPTRs decreased from 1 in 4,818 transfusions to 1 in 15,098 transfusions. The rate of SPTRs due to PCs was 5.39 times higher than that of SPTRs due to SDPs (95% CI, 1.89,12.9). CONCLUSION: The use of SDPs is a simple means of reducing SPTRs. Other measures such as sterilization will be required to eliminate all SPTRs.
Asunto(s)
Donantes de Sangre , Plaquetas , Transfusión de Plaquetas/efectos adversos , Sepsis/etiología , Adulto , Preescolar , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
A recently introduced system for antibody detection (ReACT) consists of affinity columns (AFC) that contain protein A and protein G-coated agarose. We compared the ReACT system to a conventional tube low-ionic-strength saline antiglobulin test (LISS-AGT). We selected 100 LISS-AGT positive samples with clinically important and benign antibodies of varying strengths and 130 LISS-AGT negative samples to evaluate by the AFC method. AFC tests were positive with all 84 clinically important antibodies, including 36 antibodies that reacted <= 1+ at LISS-AGT (0% falsely negative). Eleven of 16 (69%) clinically benign antibodies reacted by AFC. Five samples (2 anti-Sda, 2 anti-I, and 1 inconclusive) were negative by AFC. AFC tests were negative with all 130 samples that were negative by LISS-AGT (0% falsely positive). The AFC method showed results comparable with results obtained with a conventional tube LISS-AGT for detection of clinically important antibodies. Some unwanted, clinically benign antibodies may not be detected by the AFC method.
RESUMEN
We evaluated the performance of the Inverness Blood Grouping System (IBG Systems, Inc., Laytonsville, MD) for the ABO and D red cell grouping of patients' samples. The IBG System is a semiautomated microplate device for blood grouping and antibody detection We tested 2,051 samples using the IBG System and by manual grouping techniques. In no instance did the IBG System give a final ABO interpretation different from the final manual technique. For three samples, the JBG System's ABO interpretation was different from the manual interpretation. An error in interpretation by the technologist performing the manual testing was responsible for the discrepancies. The IBG System identified one sample as D-positive that was grouped as D-negative by manual testing. The patient's sample had been previously grouped manually as a weak D. Au other D results were in agreement. The IBG System provided ABO interpretatinns without technologist's intervention on 1,765 (86.1%) of the samples. In 153 (7.5%) of the samples, a single, equivocal reaction required visual inspection, but no repeat testing was necessary. In 133 (6.5%) of the samples, either repeat testing or reliance on only the manual results was required for final ABO group interpretation. The IBG System is a reliable and efficient alternative to manual techniques for ABO and D grouping of patients' samples.
RESUMEN
Neonatal transfusion practices during 1989 of 452 institutions involved in transfusing infants were surveyed by questionnaire. Most respondents (77%) transfused fresh frozen plasma appropriately (ie, primarily to treat coagulation disorders). However, 11% stated that their most frequent use of fresh frozen plasma was solely to treat hypovolemia, a practice generally not recommended. Seventy-eight percent of respondents transfused platelets to treat bleeding infants with blood platelet counts of less than 50 x 10(9)/L; 84% gave platelets to sick, premature neonates with counts of less than 50 x 10(9)/L whether or not bleeding was evident. Only 35% of respondents transfused granulocytes for neonatal sepsis; most institutions used buffy coats isolated from units of blood--a product readily available, but of questionable efficacy when compared with leukapheresis granulocytes. Ninety-three percent of respondents provided blood components with low risk of transmitting cytomegalovirus: components from seronegative donors were used by 84%, leukocyte-reduced products by 6%, and a combination by 10%. Thirteen percent of respondents gave gamma-irradiated blood components to all and 46% gave them to some neonates to prevent graft vs host disease. Forty-one percent did not routinely irradiate. Ten percent of respondents used leukocyte reduction instead of gamma irradiation to prevent graft vs host disease, a practice currently not advocated. Thus, national transfusion practices for neonates are variable, controversial, and, occasionally, other than those usually recommended. Additional research and educational efforts are needed to ensure optimal transfusion therapy.
Asunto(s)
Transfusión de Componentes Sanguíneos , Conocimientos, Actitudes y Práctica en Salud , Recién Nacido , Sangre/efectos de la radiación , Transfusión de Componentes Sanguíneos/estadística & datos numéricos , Infecciones por Citomegalovirus/transmisión , Rayos gamma , Granulocitos/trasplante , Humanos , Estados UnidosRESUMEN
Neonatal blood component transfusion practices during 1989 were surveyed via a questionnaire developed by the Pediatric Hemotherapy Committee of the American Association of Blood Banks. Of 1790 questionnaires mailed, 452 were selected to form the database for this analysis because they were from institutions in which neonates were transfused. Nearly all institutions contained intensive care units directed by neonatologists and were involved in the management of high-risk infants. Results from institutions serving as the primary pediatric teaching hospital of a medical school were compared with those with no medical school affiliation. Thirty-six percent of primary pediatric teaching hospitals and 52% of hospitals with no medical school affiliation performed pretransfusion testing in excess of that required, resulting in additional blood loss in neonates. Sixty-six percent of primary pediatric teaching hospitals used fresh frozen plasma to adjust the hematocrit of red blood cell concentrates prior to transfusion (a practice increasing donor exposure), compared with only 29% of hospitals with no medical school affiliation. The usual indication for small-volume red blood cell transfusions in severely ill neonates was to maintain a desired hematocrit level, whereas for stable infants, red blood cell transfusions were given to treat symptomatic anemia, rather than to maintain a predetermined hematocrit. As found in 1985, neonatal transfusion practices in 1989 were variable. However, improvements have occurred since 1985 to suggest that further research and educational efforts may serve to promote even better neonatal transfusion therapy.
Asunto(s)
Transfusión de Componentes Sanguíneos , Conocimientos, Actitudes y Práctica en Salud , Recién Nacido , Transfusión de Componentes Sanguíneos/normas , Transfusión de Componentes Sanguíneos/estadística & datos numéricos , Donantes de Sangre , Tipificación y Pruebas Cruzadas Sanguíneas , Hematócrito , Humanos , Recién Nacido/sangre , Estados UnidosRESUMEN
In 1989, guidelines for the auditing of pediatric transfusion practices were developed by the Pediatric Hemotherapy Committee of the American Association of Blood Banks (AABB) and made available to AABB members. A survey of members who requested the guidelines was conducted to determine how consistent the guidelines were with local transfusion practices and how useful they were for the conduct of audits. The majority of respondents indicated that the recommended audit criteria agreed with local practices and that most of them could be applied to their transfusion practice audits with little or no modification. An exception was that criteria for the transfusion of platelets to premature infants were considered by some to be too liberal. However, after review of the comments and the published information available, the committee elected not to revise the guidelines pertaining to platelet transfusions for premature infants. Bearing in mind that audit criteria are intended to identify circumstances in which transfusions are acceptable as reasonable therapy without need for further justification, rather than to serve as indications for transfusions, the AABB Pediatric Hemotherapy Committee guidelines for auditing pediatric transfusion practices are fairly representative of national practice.
Asunto(s)
Transfusión Sanguínea , Bancos de Sangre , Niño , Preescolar , Humanos , Lactante , Auditoría Médica , Sociedades Médicas , Estados UnidosRESUMEN
The long-term survival of serologically incompatible red cell units was measured in five patients with antibodies to high-frequency antigens. Initially, the survival of 1 ml of 51Cr-labeled incompatible red cells was measured over 1 hour. After demonstrating that the 1-hour survival times were successful (greater than 70%), each patient then received 5 ml of the same 51Cr-labeled red cells followed by the transfusion of the remainder of the red cell unit. The long-term T 1/2Cr survival for each case was patient 1 (anti-McCa), 15 days; patient 2 (anti-JMH), 12 days; patient 3 (anti-Kna), 31 days; patient 4 (anti-McCa), 12 days; and patient 5 (anti-Hya), 14 days. Each antibody tested in an in vitro homologous macrophage assay showed less than 5 percent phagocytosis. Anti-JMH was the only antibody to react with IgG subclass antisera and was determined to be IgG4. The macrophage assay, IgG subclass testing, and short-term (1 hour, 1 ml) 51Cr survival studies all indicated that the short-term survival was good. However, only the measurement of long-term survival with transfused units of serologically incompatible red cells was able to determine the actual survival, and "clinical significance" of the alloantibodies. Determining the actual long-term survival by the method described here can be of importance for patients requiring chronic red cell transfusion.
Asunto(s)
Incompatibilidad de Grupos Sanguíneos/sangre , Transfusión Sanguínea , Radioisótopos de Cromo , Envejecimiento Eritrocítico , Anciano , Femenino , Hemólisis , Humanos , Inmunoglobulina G/clasificación , Isoanticuerpos/análisis , Persona de Mediana Edad , Fagocitosis , Factores de TiempoRESUMEN
The use of type and screen (T&S) has reduced our overall crossmatch:transfusion (C:T) ratio from 2.5:1 prior to T&S to 1.9:1. Review of our progress, however, demonstrated only a partial reduction of C:T for elective cholecystectomy from 103:1 to 18:1, with only 39% T&S utilization. In addition, units crossmatched in excess of the surgical schedule for 174 high-risk patients had a C:T ratio of 18.6:1. Routine questioning of all excess orders proved unacceptable to blood bank staff and surgeons. An inflexible schedule was also deemed unacceptable. We therefore began monthly written summary reports to each surgical division listing each case in which extra crossmatching was reported and whether the units requested were transfused. These reports enabled the surgical directors to help monitor crossmatch utilization. In addition, we have reduced our C:T ratio of extra units for 405 high-risk patients to 4.0:1. T&S utilization for elective cholecystectomy has increased to 64%, and C:T has fallen to 9:1. These results demonstrate that establishing T&S can reduce the C:T ratio and patient costs; but continued attention is required to maximize the benefits of this procedure.
Asunto(s)
Bancos de Sangre/organización & administración , Tipificación y Pruebas Cruzadas Sanguíneas , Transfusión Sanguínea , Humanos , RiesgoRESUMEN
Red cell survival, IgG subclass, and mononuclear phagocyte assay studies were performed on a patient with an anti-K + K18 described previously. The 51Cr survival study with Kell negative K:18 red cells showed 76.6 percent survival at 75 minutes with 30.7 percent survival at 24 hours. The anti-K18 was characterized as IgG4 + IgG1. The mononuclear phagocyte assay was 16 percent when the serum was tested with K:18 cells. Among 54,450 ABO compatible donor units tested with this serum, no K:18- unit was found. These studies were undertaken to evaluate the clinical significance of the antibody when red cell support for a chemotherapy course was considered. Our data suggest that transfusion with K:18+ blood would be ineffective and could be used only to provide red cell support in an emergency should compatible units be unavailable.
Asunto(s)
Antígenos de Grupos Sanguíneos/inmunología , Envejecimiento Eritrocítico , Sistema del Grupo Sanguíneo de Kell/inmunología , Tipificación y Pruebas Cruzadas Sanguíneas , Femenino , Humanos , Inmunoglobulina G/clasificación , Isoanticuerpos/inmunología , Persona de Mediana Edad , FagocitosisRESUMEN
Hemolytic transfusion reactions typically are explained by red cell serologic incompatibilities. We describe a patient in whom a clinically significant red cell alloantibody could not be demonstrated, despite the occurrence of several clinically severe hemolytic reactions. Serologic studies using multiple techniques demonstrated only an anti-Bga; these studies included standard procedures as well as more sensitive experimental techniques. A 51Cr survival study using red cells from a random unit, compatible in vitro with conventional techniques, showed 72 percent survival at 1 hour and 7 percent survival at 24 hours. R2R2 (hr" (e) negative) red cells in a second 51Cr survival study showed 90 percent survival at 1 hour and 92 percent survival at 6 hours. The patient was transfused with R2R2 units which were tolerated well and survived normally. Extensive serologic testing still demonstrated only an anti-Bga. A third 51Cr survival study, 10 months after the first study, with an R1R1 (hr" (e) positive) sample showed 90 percent survival at 1 hour and 42 percent survival at 6 hours. A fourth study using a larger aliquot of R2R2 (hr"(e)negative) 51Cr-labeled red cells, examined over 2 weeks showed a near normal 21-day survival of 50 percent. These 51Cr survival studies, along with normal survival of hr" (e) negative units, suggest that this patient destroys hr" (e) positive red cells despite negative serologic testing.
Asunto(s)
Anemia Hemolítica/etiología , Envejecimiento Eritrocítico , Isoanticuerpos/análisis , Reacción a la Transfusión , Anemia Hemolítica/sangre , Incompatibilidad de Grupos Sanguíneos/diagnóstico , Radioisótopos de Cromo , Femenino , Humanos , Cuidados a Largo Plazo , Persona de Mediana Edad , Mieloma Múltiple/terapia , Sistema del Grupo Sanguíneo Rh-Hr/inmunologíaRESUMEN
Existing methods to evaluate fetal-maternal hemorrhage depend upon red blood cell agglutination or blood film elution techniques. These tests are insensitive and difficult to quantitate and reproduce. An enzyme-linked antiglobulin test was evaluated to determine its suitability for clinical testing of postpartum candidates for Rh immune globulin administration. Prepared mixtures of Rh positive fetal and Rh negative adult red blood cells approximating fetal maternal hemorrhage ratios of 0-2.0 percent were studied. In 43 assays, the enzyme-linked antiglobulin test consistently detected Rh positive fetal red blood cells in the 0.5 and 0.25 percent mixtures representing a 25 ml and a 12.5 ml hemorrhage, respectively, in a 70-kg woman. The 0.125 percent red blood cell suspension was positive in 85 percent of the assays and the 0.0625 percent suspension was positive in 56 percent of the tests. Agglutination testing by Du variant technique failed to detect 25 percent of the 0.5 percent mixtures. Only 45 percent of tests with the Rh immune globulin crossmatch detected the 0.5 percent mixture. A modified Kleihauer-Betke procedure was as sensitive, but less reproducible than the enzyme-linked antiglobulin test. Forty-seven Rh immune globulin candidates were studied to assess the quantity of fetal maternal hemorrhage. Fourteen patients (29.8%) had detectable Rh positive red blood cells by enzyme-linked antiglobulin tests but all hemorrhages were less than 12 ml; agglutination tests did not detect any fetal red blood cells. We conclude that the enzyme-linked antiglobulin test is a simple, sensitive, and objective procedure for detecting small amounts of Rh positive red blood cells in Rh negative blood and should be applicable to clinical testing of post-partum Rh immune globulin candidates.
Asunto(s)
Incompatibilidad de Grupos Sanguíneos/diagnóstico , Técnicas para Inmunoenzimas , Prueba de Coombs , Eritrocitos/inmunología , Femenino , Humanos , Embarazo , Sistema del Grupo Sanguíneo Rh-HrRESUMEN
This case report documents the demonstration of anti-K6 as the single antibody responsible for a delayed transfusion reaction. A 42-year-old white woman received three units of red blood cells for an episode of gastrointestinal bleeding from a duodenal ulcer. Twenty-three days following transfusion, laboratory and clinical evidence of hemolysis was noted. An anti-K6 was identified in the serum and in an eluate prepared from the patient's red blood cells. One of the three units transfused was positive for the K:6 antigen.
Asunto(s)
Antígenos de Grupos Sanguíneos/inmunología , Incompatibilidad de Grupos Sanguíneos/sangre , Sistema del Grupo Sanguíneo de Kell/inmunología , Adulto , Anemia Hemolítica Autoinmune/sangre , Anemia Hemolítica Autoinmune/etiología , Incompatibilidad de Grupos Sanguíneos/etiología , Femenino , Humanos , Factores de TiempoRESUMEN
A type-and-screen procedure was established whereby obstetric patients with no complications would be tested for ABO, Rh, and unexpected antibody. If the antibody screen was negative, cross matches would not be performed. Type and screen could be converted in 20 minutes to cross match, or type-specific blood would be immediately available. Our initial results with type and screen demonstrated 65.5% utilization but 399 cross matches were done for 17 transfusions (cross match/transfusion ratio of 17.6/1). The protocol was changed so that all nonbleeding patients would be typed and screened. A total of 503 of the next 563 patients (89.3%) were typed and screened; cross matches provided 33 transfusions (cross match/transfusion ratio of 4.9/1). An estimated 964 cross matches were eliminated with cost savings of $14,460 in 3 months. We concluded that the type-and-screen procedure is an effective tool in reducing the cross match/transfusion ratio and in lowering costs in obstetric patients with no compromise in patient care, even in high-risk patients.
Asunto(s)
Tipificación y Pruebas Cruzadas Sanguíneas/métodos , Transfusión Sanguínea/economía , Femenino , Humanos , Embarazo , RiesgoRESUMEN
A serum Raddon defining a low-frequency red blood cell antigen FR, and its association with the Miltenberger complex of antigens, were reported in 1977. An antibody of the same serological specificity was the cause of a transfusion reaction. The patient's reaction and serological response, as well as the frequency of Raddon and its inheritance, are described.
Asunto(s)
Anticuerpos , Antígenos de Grupos Sanguíneos/inmunología , Reacción a la Transfusión , Anciano , Femenino , Hemólisis , Humanos , Inmunoglobulina G , Sistema del Grupo Sanguíneo MNSsRESUMEN
A case of Tn polyagglutinability in a patient with acute myelomonocytic leukemia is described. This represents the third report in which Tn polyagglutination has been associated with a leukemic state. Serologic recognition of Tn polyagglutination and probable causes are discussed. Known cases of Tn-polyagglutinability are reviewed.
Asunto(s)
Aglutinación , Antígenos de Grupos Sanguíneos , Leucemia Mieloide Aguda/inmunología , Anciano , Antígenos , Eritrocitos/inmunología , Humanos , MasculinoRESUMEN
The development and implementation of a preventive maintenance program are described. The details of the program are discussed to demonstrate its initial planning and the subsequent stages as a process that would be applicable to any medical laboratory.
Asunto(s)
Laboratorios/normas , Mantenimiento/métodos , Bancos de Sangre/normas , Laboratorios/organización & administración , Control de CalidadRESUMEN
A new antibody, designated anti-K18, reacts with a high frequency red cell antigen that is related to the Kell blood group system. All of more than 2,000 bloods were K:18 but K-0 phenotype red cells are K:-18.